NysnoBio

Mill Valley, United States

NysnoBio helps patients with medical conditions develop the Parkin protein's therapeutic potential.

$2.5M raised

Jan 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NysnoBio raised?

NysnoBio has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in January 2025.

Who are NysnoBio's investors?

NysnoBio's investors include Michael J. Fox Foundation, California Institute for Regenerative Medicine.

Where is NysnoBio headquartered?

NysnoBio is headquartered in Mill Valley, United States.

What does NysnoBio do?

NysnoBio helps patients with medical conditions develop the Parkin protein's therapeutic potential.

What stage is NysnoBio at?

NysnoBio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 30, 2025.

MLA

"NysnoBio — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/nysnobio. Accessed July 2, 2026.

APA

VCBacked. (2025). NysnoBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nysnobio

Wikipedia (cite web)

{{cite web |title=NysnoBio — Funding & Investors |url=https://www.vcbacked.co/company/nysnobio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 30, 2025.